Autoimmune encephalomyelitis is a disease of the central nervous system that can develop when an initial peripheral inflammatory stimulus is followed by infiltration and reactivation of T lymphocytes in the central nervous system. We here report a crucial role for coronin 1, which is essential for maintenance of the naïve T cell pool, for the development of murine experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis. In the absence of coronin 1, immunization with MOG35-55 peptide largely failed to induce EAE symptoms, despite normal mobilization of leukocyte subsets in the blood as well as effector cytokine expression comparable to wild-type T cells upon polyclonal stimulation. Susceptibility of coronin 1-deficient mice to EAE induction was restored by transfer of wild-type CD4 + T cells, consistent with a failure of coronin 1-deficient mice to generate a MOG-specific T effector cell response. Importantly, while coronin 1-deficient regulatory T cells (Tregs) showed a suppressor activity comparable to wild-type Tregs, Treg depletion failed to restore EAE development in coronin 1-deficient animals. These results suggest a hitherto unrecognized role of naïve T cells in the development of autoimmune encephalomyelitis and reveal coronin 1 as a crucial modulator of EAE induction.
Introduction
The immune system has evolved mechanisms to respond to a diverse set of foreign antigens while minimizing the risk for auto-reactivity. T cells play an important role in ensuring a successful immune response; however, under still ill defined circumstances, T cells can cause harm to the body's own constituents and mediate autoimmune pathology. Multiple sclerosis (MS) is an inflammatory demyelinating brain disease, in which autoreactive T cells are thought to play a major role in disease pathogenesis (for review see (1) ). This immune response leads to an inflammation in the central nervous system (CNS) and subsequent demyelination and axonal injury.
Experimental autoimmune encephalomyelitis (EAE) is the commonly used animal model to study immunopathogenesis of MS. To induce active EAE, C57BL/6 mice are immunized with peptides of a CNS-derived autoantigen e.g. myelin oligoglycoprotein, MOG (2, 3) . In this form of EAE, MOG-specific naïve T cells are activated and expand during the initiation phase of the immune response in the draining lymph node. At later time points the expanded T cells invade the CNS where they are reactivated by local and infiltrating antigen-presenting cells (4, 5) and initiate the recruitment of inflammatory cells such as neutrophils and macrophages to induce the effector phase.
In this rodent model of EAE, inflammation predominantly targets the spinal cord resulting in the classic symptoms of ascending flaccid paralysis.
While Th1 cells were believed to be the main effector cell subset in this particular EAE model, recent work has highlighted the importance of Th17 cells for the pathology of EAE. To date, several studies indicate that Th1 as well as Th17 cells can induce autoimmunity in the CNS and play complementary roles in pathogenesis of EAE (6, 7) , while Th2 response are protective (8, 9) . In contrast to these effector T cell subsets, regulatory T cells have been implicated in the prevention and resolution of EAE. Increasing the number of Tregs has shown beneficial effects on EAE pathology, while decreasing Treg numbers worsened disease outcome (10) (11) (12) (13) . It thus appears that the balance between different T cell subsets, in particular Th1, Th17, Th2 and Tregs may be dictating disease outcome following immunization with myelin-derived peptides.
In healthy mice, the different T cell populations such as naïve, memory and regulatory T cells occupy their own niche in the periphery, and T cell numbers are fairly well maintained. The mechanisms underlying the maintenance of the peripheral T cell pool are incompletely understood. Naïve T cell survival in the periphery seems to depend on continuous low-level stimulation of their T cell receptor (TCR) by self-MHC molecules in secondary lymphoid organs as well as IL-7 signaling (reviewed in (14) ). In the absence of appropriate stimuli such as in mice lacking major histocompatibility complex (MHC) expression, the naïve T cell pool is greatly diminished and lymphopenia develops, that favors the enrichment of memory-like T cells (15) (16) (17) (18) . Similarly, ablation of the T cell receptor expression leads to a reduction in peripheral T cells, underscoring that peripheral T cell survival relies on TCRdependent stimulation.
Recently, coronin 1 (also known as P57 or TACO, for tryptophan aspartate containing coat protein) has been identified as a molecule essential for naïve T cell maintenance in the periphery (19) (20) (21) (22) (23) . Coronin 1, which is a leukocyte-specific molecule of the coronin protein family of WD repeat containing proteins, is essential for intracellular calcium mobilization following T cell receptor stimulation and survival of naïve T cells. Mice lacking coronin 1 have strongly reduced naïve T cell numbers in the periphery, while thymic cellularity and selection is relatively normal (19) (20) (21) (22) (23) .
Interestingly, despite strongly reduced naïve T cell numbers and the observed in vitro activation defect, coronin 1-deficient mice show relatively normal antibody responses to thymus-dependent and independent antigens (24) .
We here show that upon immunization with MOG35-55 peptide, coronin 1-deficient mice are largely resistant to EAE. Failure to induce EAE in the absence of coronin 1 occurred despite the fact that upon polyclonal stimulation, coronin 1-deficient CD4 + T cells expressed effector cytokines comparable to wild-type T cells. The transfer of wild-type CD4 + T cells prior to EAE induction could restore susceptibility to EAE.
Furthermore, despite normal regulatory T cell function in the absence of coronin 1, Tregs were not involved in EAE resistance.
These results suggest an important role for coronin 1 in the development of EAE and furthermore reveal the importance of an intact naïve T cell pool as a prerequisite for autoimmune induction.
Material and methods

Mice
Coronin 1-deficient mice were generated in our laboratory as described (25) and backcrossed to C57BL/6 for eight generations. The corresponding littermates (knockout and wild-type) were bred in-house as homozygous lines. For the EAE experiments females of age 8 to 16 weeks were used. All experiments were approved by the Kantonales Veterinäramt Basel-Stadt.
Induction of active EAE
EAE was induced by active immunization with MOG35-55 peptide based on established protocols (26, 27) . To that end, 8-12 weeks old the mice were immunized subcutaneously on the back at day 0 with 200 µg MOG35-55 peptide (Genscript) emulsified in 100 µl complete Freund´s adjuvant (Sigma) at a final volume of 200 µl.
On day 0 and 2 the animals were injected with 250 ng pertussis toxin (Sigma) in 100 µl PBS intra peritoneally. In some experiments, wild-type CD4 + T cells were transferred i.v. to coronin 1-deficient mice one day prior to EAE induction. For the CD4 + T cell sort, erythrocyte-depleted cell suspensions of lymph node and spleen from naïve wild-type mice were stained with anti-CD4-FITC antibody (clone RM4-5, Biolegend) and subsequently labeled with anti-FITC microbeads (Miltenyi Biotec).
Thereafter, the CD4 + T cells were isolated using LS columns and magnets (Miltenyi Biotec). The sort purity was above 95% on reanalysis. For Treg depletion experiments, the mice were treated with 0.5 mg anti-CD25 antibody (PC61, purified according to (28) ) i.p. 5 and 3 days before induction of EAE, which corresponds to day 0. Wild-type and coronin 1-deficient mice not treated with antibody were used as controls. The efficiency of CD25 depletion was monitored in the blood by flow cytometry at day -8, -1 and 7 by staining with an anti-CD25 antibody that recognizes an epitope different from that recognized by PC61 to avoid interference of the depleting antibody with the staining.
To monitor immune response in peripheral blood and to determine the success of T cell transfer or Treg depletion, mice were bled prior to EAE induction and during disease progression. Not more than 60 µl blood was taken from the tail vein by puncture with a 22G needle at each time point and collected in heparinized tubes.
Leukocyte counts in the erythrocyte-depleted blood were determined with a Neubauer chamber and further analyses were performed by flow cytometry.
Clinical signs of EAE were assessed daily according to the standard scoring protocol using the following scoring system: (29, 30) 0, no clinical signs; 0.5, tip tail weakness; 1, tail weakness; 1.5, mild monoparesis; 2, monoparesis or monoplegia; 2.5, mild paraparesis; 3, paraparesis, paraplegia or mild hemiplegia; 3.5, paraplegia with spasticity; 4, quadriparesis; 5, morbid stage. The mice were euthanized at score 4 or when a clinical score of 3.5 lasted for more than 2 days. In some experiments, the body weight was determined as well.
Proliferation analyses, intracellular cytokine expression and ELISA
At different time points after EAE induction the mice were scarified using high concentrations of CO2 and the spleen was removed for further in vitro analyses.
Erythrocyte-depleted splenocytes were cultured with different concentrations of MOG35-55 peptide or anti-CD3 (1 µg/ml) and anti-CD28 (2 µg/ml) antibodies in RPMI- Wilcoxon signed rank test using GraphPad Prismsoftware (GraphPad).
Results
Role for coronin 1 in the development of EAE
Coronin 1 is a leukocyte-specific regulator of Ca 2+ -dependent signaling processes and essential for the maintenance of the naïve T cell pool in the periphery (19) (20) (21) (22) .
Despite diminished numbers of naïve T cells (20) , when coronin 1-deficient mice are immunized with a variety of antigens, normal antibody responses are generated (24) .
To investigate the role of coronin 1 in the pathogenesis of T cell mediated autoimmunity, coronin 1-deficient and wild-type C57Bl/6 mice were immunized with MOG35-55 peptide emulsified in complete Freund´s adjuvant (CFA) subcutaneously together with pertussis toxin intra peritonealy leading to induction of active EAE (see materials and methods). The development of clinical signs of disease was monitored over several weeks. Initial signs of EAE, starting with tail weakness, were observed ten days (on average 11.6 ± 2.7 days) after immunization of wild-type mice while at this time point none of the coronin 1-deficient mice showed any signs of disease ( Figure 1A ). Onset and progression of disease were also reflected by weight loss To analyze the relative lesion size in spinal cords from immunized wild-type and coronin 1-deficient animals, histological sections were stained with F4/80, a marker for activated microglia/macrophages. Consistent with the aforementioned clinical EAE symptoms, all wild-type mice showed massive inflammatory lesions in the spinal cord; in contrast, only some coronin 1-deficient mice developed inflammatory lesions ( Figure 1F ). Furthermore, also confirming the clinical observations, the lesions of coronin 1-deficient spinal cord were smaller in size and observed mainly in the lumbar part, which reflects less progressed disease ( Figure 1F ). We conclude from these results that coronin 1-deficient mice are largely resistant to EAE induction.
Immune responses during EAE development in the presence and absence of coronin 1
To monitor immune responses during EAE initiation and progression in wild-type and coronin 1-deficient mice, blood samples were taken before and at several time points after immunization. Determination of leukocyte cell counts in the blood after lysis of erythrocytes revealed a strong increase in cellularity in both wild-type and Figure 3B and data not shown). Overall, MOG-specific proliferation of coronin 1-deficient splenocytes was greatly reduced in contrast to splenocytes isolated from immunized wild-type mice, which showed a dosedependent proliferation, which was strongest at onset of EAE (day12, Figure 3B ). In contrast to the diminished MOG-induced proliferation of coronin 1-deficient splenocytes, proliferation upon polyclonal stimulation was equivalent to that of wildtype splenocytes, especially at later time points after immunization. Interestingly, coronin 1-deficient splenocytes showed less proliferation upon polyclonal stimulation than wild-type cells at day 6 and day 12 after immunization, but this difference was not observed anymore at day 16, suggesting that immunization increased the proliferation capacity of coronin 1-deficient T cells to wild-type levels. (Figure 4) . Overall, the degree of immune cell infiltration correlated with the degree of disease severity in both mice strains.
Immune cell infiltration in spinal cords of wild-type and coronin 1-deficient mice upon induction of active EAE
EAE development in coronin 1-deficient mice after transfer of wild-type CD4 + T cells and subsequent immunization with MOG35-55 peptide
To analyze whether the resistance of coronin 1-deficient mice towards EAE is T cell intrinsic, CD4 + T cells isolated from naïve wild-type mice were adoptively transferred to coronin 1-deficient mice prior to immunization with MOG35-55 peptide. The presence of the transferred wild-type CD4 + T cells in the blood of coronin 1-deficient mice was monitored by flow cytometry (Suppl. Figure 3) . While the adoptive transfer of one and five million wild-type cells did not and the transfer of ten million did only slightly change the EAE outcome, the transfer of twenty million wild-type CD4 + T cells restored EAE-susceptibility in all coronin 1-deficient recipients (with the exception of one mouse that lost the transferred cells; Suppl. Figure 3 and Figure 5 ). The presence of twenty million wild-type CD4 + T cells in coronin 1-deficient mice increased the average disease incidence from 43% to 100%, the average maximal clinical score from 1.3 to 2.8 and the average day of onset from 22.7 to 17.8 (Table I) . Following transfer of wild type CD4 + T cells, the disease outcome showed a mixed phenotype:
four out of six mice developed signs of EAE that were equal in severity and day of onset to that of wild-type mice, while two recipients developed EAE, which resembled the lower grade disease observed for coronin 1-deficient mice. We conclude from these results that the resistance of coronin 1-deficient mice to EAE induction is caused by a defective T-cell response.
Frequency and functionality of regulatory T cells in the presence and absence of coronin 1
Development of autoimmune encephalomyelitis depends on the activation, expansion and migration of myelin-specific CD4 + T cells into the CNS and is controlled by regulatory T cells that suppress autoreactive T cell responses (reviewed by (33)).
Given the severely depressed EAE responses in coronin 1-deficient mice, the impact of coronin 1-deficiency on the number and functionality of Tregs was investigated. Figure 4) . While Treg depletion resulted in a more severe EAE in wild-type mice compared to mice that were not treated with antibodies, it had no effect on disease severity of coronin 1-deficient mice that remained resistant to EAE induction ( Figure 6C ). Thus, these results indicate that resistance to EAE induction in the absence of coronin 1 is not due to deregulated Treg response but is more likely caused by a disturbed naïve T cell priming. However, coronin 1-deficient mice are capable to mount relatively normal antibody responses to T cell independent as well as T cell dependent antigens (24) . The most striking effect of coronin 1-depletion is the apparent increased spontaneous apoptosis of naïve T cells ex vivo (19, 20, 23) . This observation together with the here described resistance of coronin 1-deficient mice to EAE development is in accordance with the finding that the extent of T cell death is decisive for autoimmunity (37) .
The resistance of coronin 1-deficient mice to EAE induction as describe here is consistent with a role for coronin 1 in T cell signaling. Indeed, in the absence of coronin 1, MOG-specific T cell responses such as proliferation and cytokine expression following immunization with MOG35-55 peptide are delayed as well as reduced, strongly suggesting a priming defect in the absence of coronin 1. In addition, several lines of evidence exclude a role for coronin 1 in antigen processing and presentation. These include (i) the restoration of EAE upon transfer of naïve, wildtype T cells as shown here; (ii) the absence of any defect in either macrophage, B cell and dendritic cell function (24, 25, 38) ; (iii) the absence of any gross defects in thymic selection, a process that is heavily dependent on antigen processing and presentation (19) (20) (21) . Naïve T cell priming, which is the initial step of an immune response, usually takes place the draining lymph nodes where professional antigen presenting cells activate naïve T cells leading to clonal expansion and differentiation into cytokineexpressing effector T cells. While peripheral lymph nodes of coronin 1-deficient mice are smaller compared to wild-type mice, the segregation of T and B cells is normal as well as the formation of germinal centers upon immunization (24) . However, lymph node swelling as an indication of an ongoing immune response was reduced in coronin 1-deficient mice (unpublished data), which might be due to impaired lymph node access or defective T cell activation in the lymph node. However, it has to be noted that T cell access to lymph nodes may not be essential for EAE development, since T cell priming can also occur in the spleen or extra-lymphoid structures such as in liver (39) (40) (41) .
Our results suggest a more general activation defect in coronin 1-deficient mice, since splenocytes isolated at several time points after immunization with MOG35-55 peptide Furthermore, coronin 1-deficient CD4 + T cells did not display a general defect to differentiate into effector T cells, since the cytokine-profile of wild-type and coronin 1-deficient CD4 + T cells was comparable after polyclonal stimulation. This is in line with the finding that the memory T cell pool in coronin 1-deficient mice is comparable to wild-type mice (19, 20) . However, this does not explain the observed increase of cytokine-expressing CD4 + T cells after immunization in vivo. Interestingly, expression of IL-4, which has been described to protect from EAE development (8, 9) , was even higher in coronin 1-deficient mice. But since no MOG-specific IL-4 secretion was detected, we rule out that the resistance to EAE is caused by immune deviation to a Th2 response. Another possible explanation for the increased resistance of coronin 1-deficient mice to EAE provides the elevated Treg:naïve T cell ratio that was observed in the absence of coronin 1. However, since the depletion of Tregs, which showed normal suppressive activity in vitro, did not restore EAE sensitivity, an important contribution of this T cell subset is unlikely. This finding supports the idea that the resistance of coronin 1-deficient mice to EAE development is primarily a consequence of reduced naïve T cell number and/or impaired activation upon immunization.
Nevertheless, some coronin 1-deficient mice developed EAE symptoms and displayed MOG-specific IL-17A and IFN-g secretion, which was in some cases as high as observed for wild-type mice. However, in all of these cases the disease onset was delayed, even if in these few cases disease severity was indistinguishable from wildtype mice. Consistent with the delayed disease onset of the few diseased coronin 1-deficient mice MOG-specific IL-17A and IFN-g secretion was delayed. This observation might be explained by the important role of pioneer cells for immune surveillance and for initiating immune responses in peripheral tissues (42) . After priming and differentiation in lymphoid tissues, myelin-specific effector T cells must acquire access to the non-inflamed central nervous system, where they act as pioneer T cells to induce disease. Recently, the impact of CCR6 + Th17 pioneer cells for EAE induction has been highlighted by Reboldi et al. (43) . Given the strongly reduced naïve T cell pool and the T cell activation defect of coronin 1-deficient mice, the accumulation of 
